Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
CSL Behring · NCT05485961
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Phase 2, Phase 3
- Target enrollment
- 3110
- US sites recruiting
- 149
- Study start
- April 27, 2024
- Record last updated
- September 21, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a two-part, phase 2b and phase 3 combined prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study.
Part 1: Phase 2b is a dose-finding study for CSL300 vs placebo. Part 2: Phase 3 aims to assess the efficacy of CSL300 vs placebo on cardiovascular (CV) outcomes and safety in subjects with systemic inflammation and either atherosclerotic cardiovascular disease (ASCVD) or diabetes with end stage kidney disease (ESKD) undergoing maintenance dialysis.
Being studied: CSL300; Placebo
Conditions: End Stage Kidney Disease
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Male or female at least 18 years of age.
- A diagnosis of ESKD undergoing maintenance dialysis for at least 12 weeks.
- Serum hs-CRP ≥ 2.0 mg/L.
- A diagnosis of diabetes mellitus OR ASCVD.
Exclusion Criteria
- Subjects who participated in Part 1 (phase 2b) are not eligible to participate in Part 2 (phase 3).
- Concomitant use of systemic immunosuppressant drugs.
- Part 1 (Phase 2b) excludes subjects with a positive TB or a history of latent TB, whereas Part 2 (Phase 3) excludes active TB but allows inclusion of subjects with a latent TB and at least 4 weeks of prophylactic TB treatment.
- Abnormal LFTs.
- Any life-threatening disease expected to result in death within 12 months.
- A history of GI perforation, inflammatory bowel disease (except fully excised. ulcerative colitis), or peptic ulcer disease.
- Clinically significant active infection or history of opportunistic or invasive fungal infection.
Recruiting US locations
Nephrology of North Alabama
Decatur, AL 35601
Nephrology Consultants, LLC
Huntsville, AL 35805
Site contact: Use Central Contact
DaVita Clinical Research Montgomery
Montgomery, AL 36117
Site contact: Use Central Contact
AKDHC Medical
Glendale, AZ 85305
Site contact: Use Central Contact
Kidney Disease Medical Group
Glendale, AZ 91206
Site contact: Use Central Contact
AKDHC Medical
Phoenix, AZ 85018
Site contact: Use Central Contact
AKDHC Medical
Tucson, AZ 85705
Site contact: Use Central Contact
Southern Arizona VA Health Care System
Tucson, AZ 85723
Site contact: Trial Information Contact
National Institute of Clinical Research
Bakersfield, CA 93309
Site contact: Use Central Contact
California Institute of Renal Research
Chula Vista, CA 91910
Site contact: Use Central Contact
The Medical Research Group, Inc.
Fresno, CA 93720
Davita Fullerton Dialysis Center
Fullerton, CA 92832
Site contact: Use Central Contact
National Institute of Clinical Research, Inc.
Fullerton, CA 92835
Site contact: Use Central Contact
National Institute of Clinical Research, Inc.
Garden Grove, CA 92843
Site contact: Use Central Contact
St. Jude Medical Center
Garden Grove, CA 92843
Site contact: Use Central Contact
National Institute of Clinical Research
Garden Grove, CA 92844
Site contact: Use Central Contact
Sherman Medical Group, Inc
Glendale, CA 91204
Site contact: Use Central Contact
Kidney Disease Medical Group
Glendale, CA 91206
Site contact: Use Central Contact
Renal Consultants Medical Group
Granada Hills, CA 91344
Site contact: Use Central Contact
Balboa Research
La Jolla, CA 92037
Site contact: Trial Information Contact
California Institute of Renal Research
La Mesa, CA 91942
Site contact: Use Central Contact
Southern California Medical Research Center
La Palma, CA 90623
Site contact: Use Central Contact
Academic Medical Research Institute
Los Angeles, CA 90022
Site contact: Use Central Contact
National Institute of Clinical Research, Inc.
Los Angeles, CA 90027
Site contact: Use Central Contact
Cedars-Sinai Medical Center
Los Angeles, CA 90048
Renal Medical Associates/NARI
Lynwood, CA 90262
Site contact: Use Central Contact
Amicis Research Center
Northridge, CA 91324
Site contact: Use Central Contact
FORMAT Medical Research
Oxnard, CA 93036
Site contact: Use Central Contact
National Institute of Clinical Research, Inc.
Pomona, CA 91768
Van Buren Dialysis Center
Riverside, CA 92504
Site contact: Use Central Contact
National Nephrology Alliance Research - Riverside
Riverside, CA 92505
Site contact: Use Central Contact
Central Coast Nephrology Medical Corp
Salinas, CA 93901
Site contact: Use Central Contact
California Institute of Renal Research
San Diego, CA 92111
Site contact: Use Central Contact
North America Research Institute
San Dimas, CA 91773
Site contact: Use Central Contact
Nephrology Educational Services
Tarzana, CA 91356
Site contact: Use Central Contact
Valiance Clinical Research
Tarzana, CA 91356
Site contact: Use Central Contact
National Institute of Clinical Research, Inc
Victorville, CA 92392
Site contact: Use Central Contact
DaVita Vista Del Sol Dialysis
Victorville, CA 92394
Site contact: Use Central Contact
Western Nephrology
Arvada, CO 80002
Site contact: Trial Information Contact · 303-232-3366 · kmydosh@westneph.com
Kidney Associates of Colorado, P.C.
Denver, CO 80210
Site contact: Use Central Contact
Colorado Kidney Care
Denver, CO 80230
Site contact: Use Central Contact
Greater Hartford Nephrology, LLC
Bloomfield, CT 06002
Site contact: Use Central Contact
Nephrology and Hypertension Associates PC
Middlebury, CT 06762
Site contact: Use Central Contact
- Boca Raton Regional - Research Physicians Network Alliance
Boca Raton, FL 33431
Site contact: Use Central Contact
Nova Clinical Research, LLC
Bradenton, FL 34209
Site contact: Trial Information Contact · 941-792-6564 · sade.andrews@novaclinicalresearch.com
South Florida Nephrology Group, PA
Coral Springs, FL 33071
Site contact: Use Central Contact
Family First Medical Research Center
Hialeah Gardens, FL 33016
Site contact: Use Central Contact
Advanced Medical Research Group
Hollywood, FL 33021
Site contact: Use Central Contact
Royal Research, Corp
Hollywood, FL 33021
Elixia Pines
Hollywood, FL 33024
Site contact: Use Central Contact
South Florida Research Institute
Lauderdale Lakes, FL 33313
Site contact: Use Central Contact
South Florida Research Organization LLC
Medley, FL 33166
Site contact: Use Central Contact
Aviva Health Sciences
Miami, FL 33125
Iconic Clinical Research Center
Miami, FL 33126
Site contact: Use Central Contact
Total Research Group, LLC
Miami, FL 33126
Site contact: Use Central Contact
Nephrology Associates of South Miami
Miami, FL 33173
Site contact: Use Central Contact
Floridian Clinical Research
Miami Lakes, FL 33016
Site contact: Use Central Contact
Infigo Clinical Research LLC
Sanford, FL 32771
Florida Kidney Specialists
Temple Terrace, FL 33637
Site contact: Use Central Contact
Florida Premier Research Institute
Winter Park, FL 32789
Site contact: Use Central Contact
+ 89 more on the official record.
Study contacts (from the official record)
- Trial Registration Coordinator · +1 610-878-4697 · clinicaltrials@cslbehring.com
Similar studies in Alabama
All diabetes studies in Alabama →- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Birmingham, AL + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingPhase 2
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
Biomea Fusion Inc.
- Location
- Birmingham, AL + 19 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
Sonavex, Inc.
- Location
- Dothan, AL + 19 other US sites
- Eligibility basics
- Ages 18–84
- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- Anniston, AL + 57 other US sites
- Eligibility basics
- Ages 18–80